AXA Framlington Biotech Fund GBP Z Acc

Investment Style Details31/05/2020
Morningstar Style Box®
Equity Style
SizeRel to Cat
Average Mkt Cap (Mil)GBP 11889-
Market Capitalisation% of Equity
Giant7.31
Large42.32
Medium25.56
Small20.42
Micro4.39
Valuations and Growth RatesEquity PortfolioRelative to Category
Price/Prospective Earnings17.310.76
Price/Book4.700.93
Price/Sales5.380.72
Price/Cash Flow13.150.74
Dividend-Yield Factor0.441.27
 
Long-Term Projected Earnings Growth9.450.61
Historical Earnings Growth28.131.07
Sales Growth14.181.24
Cash-Flow Growth19.101.53
Book-Value Growth5.170.49
 
Asset Allocation31/05/2020
Asset Allocation
 % Long% Short% Net Assets
Stock95.700.0095.70
Bond0.000.000.00
Property0.000.000.00
Cash3.930.493.44
Other0.870.000.87
World Regions31/05/2020
 % of EquityRelative to Category
United States90.161.06
Canada0.000.00
Latin America0.00-
United Kingdom1.020.57
Eurozone3.910.93
Europe - ex Euro2.330.82
Europe - Emerging0.00-
Africa0.00-
Middle East0.000.00
Japan0.000.00
Australasia0.000.00
Asia - Developed0.000.00
Asia - Emerging2.580.83
 
Sector Weightings31/05/2020
 % of EquityRelative to Category
HealthcareHealthcare100.001.01
 
Top 10 Holdings31/05/2020
 Portfolio
Total Number of Equity Holdings54
Total Number of Bond Holdings0
Assets in Top 10 Holdings49.60
NameSectorCountry% of Assets
Regeneron Pharmaceuticals Inc206United States7.78
Amgen Inc206United States7.00
Biogen Inc206United States6.58
Alexion Pharmaceuticals Inc206United States5.09
Vertex Pharmaceuticals Inc206United States4.71
Gilead Sciences Inc206United States4.66
Seattle Genetics Inc206United States3.85
Incyte Corp206United States3.65
Illumina Inc206United States3.17
Biomarin Pharmaceutical Inc206United States3.10
 
 
Advertisement
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies